throbber
Journal of Dermatological Treatment (2003) 14, 1–3
`# 2003 Journal of Dermatological Treatment. All rights reserved. ISSN 0954-6634
`
`1
`
`The treatment of atopic dermatitis with licorice gel
`
`M Saeedi1, K Morteza-
`Semnani2 and M-R Ghoreishi3
`
`Departments of 1Pharmaceutics and
`2Medicinal Chemistry, Faculty of
`Pharmacy, Mazandaran University of
`Medical Sciences, Sari, Iran;
`3Dermatologist, Sari, Iran
`
`Glycyrrhiza glabra L. has been
`used in herbal medicine for skin
`eruptions,
`including dermatitis,
`eczema, pruritus and cysts. The
`effect of licorice extract as topi-
`cal preparation was evaluated on
`atopic dermatitis. The plant was
`collected and extracted by per-
`colation with suitable solvent.
`The extract was standardized,
`based on Glycyrrhizinic acid by
`using
`a
`titrimetry method.
`Different topical gels were for-
`mulated by using different co-
`solvents. After standardizing of
`topical preparations,
`the best
`formulations (1% and 2%) were
`studied in a double–blind clinical
`trial in comparison with base gel
`on atopic dermatitis over two
`
`in each
`(30 patients
`weeks
`group). Propylene glycol was
`the best
`co-solvent
`for
`the
`extract and Carbopol 934P as
`gelling agent showed the best
`results in final formulations. The
`quantity of glycyrrhizinic acid
`was determined 20.3% in the
`extract and 19.6% in the topical
`preparation. Two percent licor-
`ice topical gel was more effective
`than 1% in reducing the scores
`for erythema, oedema and itch-
`ing over two weeks (p,0.05).
`The results showed that licorice
`extract could be considered as
`an effective agent for treatment
`of atopic dermatitis. (J Dermatol
`Treat (2003) 14: 000–000)
`
`Received 20 September 2002
`Accepted 3 June 2003
`
`Keywords: Atopic dermatitis — Glycyrrhiza glabra — Oedema —
`Erythema — Itching
`
`Introduction
`
`Atopic dermatitis is the cutaneous expression of the atopic
`state, characterized by a family history of asthma, hay
`fever, or dermatitis in up to 70% of patients.1 Hanifin
`summarized four current hypotheses concerning the cause
`of atopic dermatitis in his review: cyclic nucleotide
`dysfunction, the role of superantigen, Ig-E mediated allergy
`to airborne and food allergens, and autoimmunity to self-
`antigen .2 Topical corticosteroid creams or ointments are
`the mainstay of therapy to control the acute flares of atopic
`dermatitis, probably due to their broad immunomodula-
`tory effects.3,4 As these and other therapies have side effects
`it is necessary to evaluate new therapeutic methods. A
`traditional Chinese medication consisting of a mixture of
`several herbs, especially Glycyrrhiza uralensis (a Chinese
`species of licorice) has provided a therapeutic option for
`children with extensive atopic dermatitis.5,6 Chinese
`licorice root (G. Uralensis) which is a staple herb for skin
`disease in east Asia, contains steroid-like substances,
`
`Correspondence:
`M. Saeedi, Faculty of Pharmacy, Taleghani Blvd., P.O.Box: 48175-861,
`Sari, Iran; Tel/Faxz151-3243109. E-mail: saeedi_m_2001@yahoo.co.uk
`
`which, when taken internally, or even applied topically,
`rapidly provide relief.7
`to Eurasia and
`is native
`Glycyrrhiza
`glabra L.
`cultivated in Europe (e.g. Spain,
`Italy, France),
`the
`Middle East (e.g. Syria, Iran, Turkey, Iraq), and Asia.
`Those parts used are the dried roots collected in the
`autumn.8 G. glabra contains substantial amounts of
`flavones,
`such as
`liquiritigenin and liquiritin, and
`triterpenoids, such as glycyrrhetinic acid and glycyr-
`rhizin. Liquiritigenin, disodium glycyrrhetinic acid and
`glycyrrhizin
`have
`been
`shown
`to
`have
`anti-
`inflammatory activity.9–11 Glycyrrhiza glabra has signi-
`ficant anti-inflammatory and anti-allergic activity.
`Glycyrrhizin reinforces cortisol’s inhibition of antibody
`formation, stress reaction, and inflammation. Alcohol
`extract of G. glabra has displayed anti-microbial activity
`in vitro against Staphylococcus aureus, Streptococcus
`mutans, Mycobacterium smegmatis, and Candida albicans.
`The majority of the antimicrobial effects are due to
`soflavenoid components, with the saponins having a
`lesser antibacterial effect.12 This study was designed to
`compare the clinical efficacy of licorice gel (1% and 2%)
`with that of placebo, in patients with atopic dermatitis.
`
`JDT: (gamma) JDT24951.3d 3/7/03 13:07:11 Rev 7.51n/W (Jan 20 2003)
`
`The Charlesworth Group, Huddersfield 01484 517077
`
`262
`
`Apotex, Inc. (IPR2019-00400), Ex. 1017, p. 001
`
`

`

`2
`
`M Saeedi et al
`
`The treatment of atopic dermatitis
`
`Materials and methods
`
`Materials
`
`The following chemicals were used as received from the
`suppliers. Methyl and propyl paraben, propylene glycol,
`PEG 200, PEG 300, PEG 400,
`isopropyl alcohol,
`glycerin, triethanolamine, methanol, acetone, ethanol,
`NaOH, NH3,
`formalin (Merck), Carbopol 940 (BF
`Goodrich).
`
`Plant material
`
`Glycyrrhiza glabra L. roots were collected from Shiraz, in
`the south of Iran, in spring 2001. The dried roots were
`powdered so that all
`the material could be passed
`through a mesh size no larger than 0.5 mm.
`
`Extraction procedure
`
`(600 g) were macerated in 1 l of
`Powdered roots
`methanol
`for one day, and the step was repeated
`twice, following by filtration through filter paper. The
`filtrate was evaporated to dryness under
`reduced
`pressure and weighed (122 g, 20.33%).
`
`Glycyrrhizic acid determination
`
`The licorice extract (2 g) was stirred with 20 ml of 3%
`HNO3 in acetone for 1 hour, then filtered and washed
`with 10 ml of acetone. The residue was refluxed with
`20 ml of acetone, filtered again, and this operation
`repeated three times. The combined acetone extracts
`were diluted to 100 ml, and washed down with 40 ml of
`ethanol; 0.9 ml of 30% NH3 was added dropwise to the
`mixture. Ammonium glycyrrhizate was filtered, washed
`2–3 time with acetone (50 ml total), and dissolved in
`25 ml of water; 20 ml of formalin was added and after
`1 min the mixture was titrated with 0.1 N NaOH in the
`presence of phenolphthalein as indicator.13 This method
`was also used for determination of glycyrrhizic acid in
`licorice preparations. The assay was repeated three
`times.
`
`Preparation of the formulations
`
`PEG 200, 300, 400, isopropyl alcohol and propylene
`glycol were used as co-solvent for dried extract and
`propylene glycol was chosen as the best
`levigator.
`Table I shows the constituents of the selected prepara-
`tions. Carbopol 940 was dispersed in preserved water
`(methyl paraben 0.18% and propyl paraben 0.02%) and
`glycerin overnight. The
`extract was dissolved in
`propylene glycol and was added to the polymer
`dispersion and stirred with a double bladed mixer
`(Ika-werk, Germany) at 500 rpm for 10 min, and
`neutralized by triethanolamine to pH 6.4 and then
`
`Formulation*
`
`Composition % (w/w)
`
`Licorice
`extract
`
`Carbopol
`
`Propylene
`glycol
`
`Glycerin
`
`F1
`F2
`F3
`F4
`F5
`F6
`F7
`F8
`F9
`F10
`F11
`F12
`F13
`F14
`F15
`F16
`F17
`F18
`F19
`Placebo
`
`1
`1
`1
`1
`1
`1
`1
`1
`1
`1
`1
`1
`1
`1
`1
`2
`2
`2
`2
`–
`
`0.30
`0.30
`0.30
`0.40
`0.40
`0.50
`0.50
`0.50
`0.50
`0.75
`0.75
`0.75
`1.00
`1.00
`1.00
`0.25
`0.50
`0.75
`1.00
`0.50
`
`10
`15
`20
`15
`20
`10
`15
`20
`20
`10
`15
`20
`10
`15
`20
`20
`20
`20
`20
`20
`
`5
`5
`5
`5
`5
`5
`5
`–
`5
`5
`5
`5
`5
`5
`5
`5
`5
`5
`5
`5
`
`*Each formulation consists of preserved water (propyl paraben
`0.02% w/w and methyl paraben 0.18% w/w) to 100 g. The
`formulations was neutralized by triethanolamine to pH=6.8.
`
`Table I
`Formulations composition
`
`mixed at 300 rpm for 10 min. The formulations were
`stored at 4, 25, and 40‡C to ensure physical stability
`evaluation for two weeks. Final
`formulations for the
`clinical trial were controlled microbiologically based on
`USP XXIV.
`
`Clinical trial and statistical analysis
`
`The study was a randomized (simple-random sampling),
`double blind, prospective, placebo-controlled trial. The
`primary endpoint of
`the clinical
`trial
`is severity in
`oedema, itching and erythema. On the assumption of an
`overall mean difference of 0.5 units and a standard
`deviation of 0.5 units, 78 patients (26 in each group)
`were required to achieve a power of 95% to reject a null
`hypothesis of equality, applying a two-sided test at the
`5% significance level. With an estimated fraction of 35%
`of the patients being not evaluable, a total of 108
`patients, aged over 15 years, with clinically diagnosed
`mild to moderate degrees of atopic dermatitis
`(1.
`pruritus and scratching, 2. course marked by exacer-
`bation and remissions, 3. lesions typical of eczematous
`dermatitis, 4. personal or family history of atopy, 5.
`clinical course lasting longer than 6 weeks) were
`recruited.1 Before enrollment
`to the study, written
`informed consent was obtained from all patients or
`the parents of those under the age of 18 years. Patients
`receiving systemic or topical steroids, antibiotics, or
`
`JDT: (gamma) JDT24951.3d 3/7/03 13:08:32 Rev 7.51n/W (Jan 20 2003)
`
`The Charlesworth Group, Huddersfield 01484 517077
`
`262
`
`Apotex, Inc. (IPR2019-00400), Ex. 1017, p. 002
`
`

`

`M Saeedi et al
`
`The treatment of atopic dermatitis
`
`3
`
`other effective topical therapy within the previous 7
`days, pregnant women, nursing mothers, and patients
`with other
`skin disorders were excluded. Lesions
`location was classified as head and neck,
`trunk,
`hands, and feet.
`The topical preparations (1% and 2% licorice gels and
`placebo) were administered to patients, in three groups,
`three times a day for two weeks. The overall clinical
`response was assessed by the investigator based on effect
`on oedema, itching, erythema and scaling, according to
`the following 4 -point
`scale: absent=0, mild=1,
`moderate=2, and severe=3. Follow up of patients
`ceased after two weeks. ANOVA, followed by Student-
`Newman-Keuls test, was used to determine significant
`differences between groups and p,0.05 was considered
`significant.14
`
`Results and discussion
`
`the
`Licorice contains as its major active ingredient
`triterpene glycoside glycyrrhizin (also known as glycyr-
`rhizic or glycyrrhizinic acid) in concentrations ranging
`from 1% to 24%, depending on sources and methods of
`assay. Glycyrrhizin on hydrolysis yields glycyrrhetinic
`(or glycyrrhetic) acid and two molecules of glucoronic
`acid.8 Thus the standardization of licorice extract and its
`preparations were performed by determination of glycyr-
`rhizinic acid. From the glycyrrhizic acid determination
`conducted according to the previously described
`method, the quantity of glycyrrhizic acid obtained was
`20.3±0.81% and 19.6±0.74% in licorice extract and
`licorice gel respectively. All investigated formulations in
`the clinical trial used the criteria of USP microbial
`limitation.
`On observing the clinical features of atopic dermatitis,
`some of them showed resistance to topical steroids and
`were even exacerbated by application of steroids, so it is
`likely that
`long term topical use of steroids may
`modulate the barrier-immunity function of the skin.
`The present study compared the efficacy of up to two
`weeks treatment with 1% and 2% licorice extract as a
`herbal gel with placebo in patients with a clinical
`diagnosis of atopic dermatitis.
`A total of 108 patients were recruited in the present
`study by a single investigator. 18 patients were
`excluded from the efficacy analyses. Nine patients
`were given systemic antibiotics, five patients were
`pregnant, one patient was a nursing mother and
`three patients were suffering from other skin disorders.
`All of the 90 evaluable subjects complete two weeks
`treatment. Table II
`shows patient characteristics
`in
`several groups.
`the overall clinical responses,
`The assessment of
`relative to baseline, at the end of treatment after one
`and two weeks is shown in Figure 1. Treatment with 1%
`and 2% licorice gel resulted in a statistically significant
`
`Licorice extract
`(1%)
`
`Licorice extract
`(2%)
`
`Placebo
`
`32.7
`16–51
`
`Age
`Mean
`Range
`Sex
`13
`Male
`17
`Female
`Duration of eczema (years)
`Mean
`3.8
`Range
`0.01–25
`Area of eczema
`Head and neck
`Trunk
`Hands
`Feet
`
`8
`3
`18
`1
`
`34.1
`16–49
`
`35.3
`17–53
`
`12
`18
`
`10
`20
`
`3.5
`0.01–21
`
`3.6
`0.01–25
`
`9
`2
`19
`–
`
`7
`2
`19
`2
`
`Table II
`The comparison of patient characteristics
`
`reduction in the scores for erythema after two weeks
`(p,0.05). This effect was not observed for 1% extract
`gel after one week (pw0.05). The 2% licorice gel
`showed more reduction in the scores for erythema than
`1% extract at
`the end of first and second weeks
`(p,0.05). The licorice extract treatment was signifi-
`cantly more effective than baseline in reducing the
`scores for oedema and itching after one week (p,0.05)
`and two weeks (p,0.01), and 2% licorice gel was more
`effective than 1% extract at the end of first and second
`weeks (p,0.05). Treatment with licorice extract was
`not significantly effective in reducing the scores of
`scaling (pw0.05). The effect of 1% and 2% licorice gel
`in reducing in reducing the scores for erythema, oedema
`and itching were significantly more than placebo after
`one and two weeks (p,0.01).
`Baseline evaluation showed that treatment groups
`were well balanced in respect of number per group, age
`and sex distribution, previous eczema treatment and
`severity of signs and symptoms of eczema.
`At
`the end of
`the treatments,
`the reduction of
`erythema scores was 35.02% for 1% licorice extract
`and 60.76% for 2% licorice gel. The reduction of
`oedema scores was 56.64% and 83.76% for 1% and 2%
`licorice gel treatment after two weeks respectively. At
`the end of the treatments, the reduction of
`itching
`scores was 44.1% and 72.53% for 1% and 2% licorice
`gel respectively. A study carried out in 1994 reinforced
`the excellent reputation of Glycyrrhiza glabra in atopic
`dermatitis. Thirty-seven children were given a Chinese
`herbal medicine containing licorice (and some other
`plants) orally. After one year, 18 of the children had
`experienced at least a 90% reduction in their symp-
`toms.6 Another study showed that
`topical steroids
`exacerbated the dermatitis in about one third of the
`patients15 but no side effects were observed in treatment
`with licorice topical gel.
`
`JDT: (gamma) JDT24951.3d 3/7/03 13:08:33 Rev 7.51n/W (Jan 20 2003)
`
`The Charlesworth Group, Huddersfield 01484 517077
`
`262
`
`Apotex, Inc. (IPR2019-00400), Ex. 1017, p. 003
`
`

`

`4
`
`M Saeedi et al
`
`The treatment of atopic dermatitis
`
`Figure 1
`Investigator assessment of overall clinical response, A: Erythema scores, B: Oedema scores, C: Scaling scores, D: Itching scores;
`
`Conclusion
`
`Finally we would like to summarize the current approach
`with regard to the management of atopic dermatitis. The
`final goal of
`the treatment
`is to give patients the
`opportunity for improved social activities in their daily
`
`life. Skin care, control of pruritus and exclusion of the
`exacerbating factors are three facets of the therapy and the
`appropriate use of topical licorice preparations in consider-
`ing the patients’ response to this excellent therapeutic tool.
`The use of 2% licorice extract gives satisfactory effects in
`treatment of atopic dermatitis.
`
`References
`1. Swerlick RA, Lawley TJ, Eczema, psoriasis, cutaneous
`infection, acne, and other common skin disorders. In:
`Fauci AS, Braunwald E,
`Isselbacher KJ, Wilson JD,
`Martin JB, Kasper DL, Hauser SL, Longo DL (eds).
`Harrison’s principles of internal medicine, Mc. Grow-Hill:
`New York, 1998, pp: 298.
`
`2. Hanifin JM, Critical evaluation of food and mite allergy
`in the management of atopic dermatitis. J. Dermatol.
`(1997) 24: 495–503.
`topical steroids in
`3. Lane AT, Efficacy and safety of
`pediatric atopic dermatitis.
`J. Eur. Acad. Dermatol.
`Venerol. (1997) 8(suppl.): S24–S27.
`
`JDT: (gamma) JDT24951.3d 3/7/03 13:08:33 Rev 7.51n/W (Jan 20 2003)
`
`The Charlesworth Group, Huddersfield 01484 517077
`
`262
`
`Apotex, Inc. (IPR2019-00400), Ex. 1017, p. 004
`
`

`

`M Saeedi et al
`
`The treatment of atopic dermatitis
`
`5
`
`4. Ramsay CA, Savoie JM, Gilbert M, Gidon M, Kidson P,
`The treatment of atopic dermatitis with topical fusidic
`acid and hydrocortisone acetate. J. Eur. Acad. Dermatol.
`Venerol. (1996) 7(suppl. 1): S15–S22.
`5. Sheehan MP, Atherton DJ, A controlled trial of
`traditional Chinese medicinal plants in wide spread
`non-exudative atopic eczema. Br. J. Dermatol. (1992)
`126: 179–184.
`follow up to
`6. Sheehan MP, Atherton DJ, One-year
`children treated with Chinese medicinal herbs
`for
`atopic eczema. Br. J. Dermatol. (1994) 130: 488–493.
`7. Tamir S, Eizenberg M, Somjen D,
`Izrael S, Vaya J,
`Estrogen-like activity of glabrene and other constituents
`isolated from licorice root. J. Steroid Biochem. Mol. Bio.
`(2001) 78: 291–298.
`8. Leung AY, Foster S., Encyclopedia of common natural
`ingredients used in food, drugs and cosmetics, Wiley
`Interscience: USA, 1996, pp: 346–348.
`9. Yuan R, Lin Y, Traditional Chinese medicine: an
`approach to scientific proof and clinical validation.
`Pharmacology & Therapeutics. (2000) 86: 191–198.
`
`10. Khaksa G, Zolfaghari ME, Dehpour AR, Samadian T,
`Anti-inflammatory and anti-nociceptive activity of dis-
`odium glycyrrhetinic acid and hemiphtalate. Planta Med.
`(1996) 62: 326–328.
`11. Pisanty S, Segal R, Glycyrrhizin as a vehicle for
`iodoxuridine.
`J. Clin. Pharm. Ther.
`(1987) 12(Jun):
`165–171.
`of natural medicine. 2nd
`12. Pizzorno J, Textbook
`Macmillan Press: London, 1999, pp: 767–772.
`13. Znakov T, Determination of glycyrrhizic acid in licorice
`root extracts. Med. Prom. SSSR. (1963) 4: 35.
`14. Atakan N, Erdem C, The efficacy, tolerability and safety
`of a new oral
`formulation of Sandimum– Sandimum
`Neoral
`in severe refractory atopic dermatitis. J. Eur.
`Acad. Dermatol. Venerol. (1998) 240–246.
`15. Katayama I, Taniguchi H, Matsunaga T, Yokozeki H,
`Nishioka K, Evaluation of non-steroidal ointment
`therapy for adult type atopic dermatitis. J. Dermatol.
`Sci. (1997) 14: 37–44.
`
`edn.
`
`JDT: (gamma) JDT24951.3d 3/7/03 13:08:41 Rev 7.51n/W (Jan 20 2003)
`
`The Charlesworth Group, Huddersfield 01484 517077
`
`
`
`View publication statsView publication stats
`
`262
`
`Apotex, Inc. (IPR2019-00400), Ex. 1017, p. 005
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket